Malik Haider, Malik Hamza, Uderani Muskan, Berhanu Mefthe, Soto Cuauhtemoc Jeffrey, Saleem Faraz
Medical School, Shifa Tameer-E-Millat University Shifa College of Medicine, Islamabad, PAK.
Medical School, Foundation University Medical College, Rawalpindi, PAK.
Cureus. 2023 Apr 25;15(4):e38101. doi: 10.7759/cureus.38101. eCollection 2023 Apr.
Acute liver failure (ALF) is a severe clinical condition with a high mortality rate. Although several factors can cause ALF, viral hepatitis remains one of the leading causes. Hepatitis A virus (HAV) and hepatitis E virus (HEV), which typically cause self-limiting acute disease, are rare but emerging causes of ALF, especially when both viruses infect the same individual. Both of these hepatotropic viruses share an enteric route and are most commonly transmitted through the fecal-oral route. The impact of HAV/HEV co-infection on acute hepatitis prognosis is not entirely understood, but dual infection can further exacerbate liver damage, leading to fulminant hepatic failure (FHF) with a higher mortality rate than a single virus infection. Here, we present a case of a 32-year-old male with no prior liver disease who presented to the emergency department with a two-week history of jaundice, abdominal pain, and hepatomegaly. Upon admission, he was disoriented with grade 2 encephalopathy. After a thorough investigation, co-infection with hepatitis A and E was identified as the primary cause of his ALF. The patient underwent intensive medical treatment and interventions, including dialysis. Unfortunately, the patient's survival was not possible due to the absence of availability of a transplanted organ, which is currently the only definitive treatment option. This case report underscores the significance of prompt diagnosis, timely intervention, and the accessibility of transplantation in the survival of liver failure, as it remains the sole definitive treatment for acute liver failure. Moreover, it provides a concise overview of the current literature on fulminant co-infection of HAV and HEV, including epidemiology, clinical characteristics, pathogenesis, diagnosis, treatment, and risk factors associated with co-infection of hepatitis A and E and their role in causing ALF. It also highlights the significance of identifying high-risk populations and implementing appropriate prevention and control measures such as vaccination, practising good hygiene and sanitation, and avoiding the consumption of contaminated food and water.
急性肝衰竭(ALF)是一种严重的临床病症,死亡率很高。尽管有多种因素可导致ALF,但病毒性肝炎仍是主要病因之一。甲型肝炎病毒(HAV)和戊型肝炎病毒(HEV)通常引起自限性急性疾病,是导致ALF的罕见但正在增多的病因,尤其是当这两种病毒感染同一个体时。这两种嗜肝病毒都通过肠道途径传播,最常见的传播方式是粪口途径。HAV/HEV合并感染对急性肝炎预后的影响尚未完全明确,但双重感染会进一步加重肝损伤,导致暴发性肝衰竭(FHF),其死亡率高于单一病毒感染。在此,我们报告一例32岁男性病例,该患者既往无肝脏疾病史,因黄疸、腹痛和肝肿大两周就诊于急诊科。入院时,他出现定向障碍,伴有2级肝性脑病。经过全面检查,确诊甲型和戊型肝炎合并感染是其ALF的主要病因。患者接受了包括透析在内的强化药物治疗和干预措施。不幸的是,由于缺乏可用于移植的器官,患者最终未能存活,而移植目前是唯一的确定性治疗选择。本病例报告强调了及时诊断、及时干预以及移植可及性对于肝衰竭患者生存的重要性,因为移植仍然是急性肝衰竭唯一的确定性治疗方法。此外,它简要概述了当前关于HAV和HEV暴发性合并感染的文献,包括流行病学、临床特征、发病机制、诊断、治疗以及与甲型和戊型肝炎合并感染相关的危险因素及其在导致ALF中的作用。它还强调了识别高危人群以及实施适当预防和控制措施的重要性,如接种疫苗;保持良好的个人卫生和环境卫生;避免食用受污染的食物和水。